Neuro Endocrine (Carcinoid) Carcinoma Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 122 pages | ID: ND41AA48DCBEN
VPAResearch

Abstracts

Neuro Endocrine (Carcinoid) Carcinoma ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Neuro Endocrine (Carcinoid) Carcinoma disease clinical trials. The research work analyzes the ongoing Neuro Endocrine (Carcinoid) Carcinoma clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Neuro Endocrine (Carcinoid) Carcinoma treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Neuro Endocrine (Carcinoid) Carcinoma clinical trials.

Scope of the Report-

• Ongoing Neuro Endocrine (Carcinoid) Carcinoma clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Neuro Endocrine (Carcinoid) Carcinoma
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Neuro Endocrine (Carcinoid) Carcinoma clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Neuro Endocrine (Carcinoid) Carcinoma Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials by Phase
3.2 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials by Type
3.3 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials
4.2 Top 10 Countries conducting Neuro Endocrine (Carcinoid) Carcinoma Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials by Sponsor Type
5.2 Neuro Endocrine (Carcinoid) Carcinoma Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Neuro Endocrine (Carcinoid) Carcinoma Trials by year
6.2 Subjects Recruited for Neuro Endocrine (Carcinoid) Carcinoma Trials by Phase
6.3 Subjects Recruited for Neuro Endocrine (Carcinoid) Carcinoma Trials by Trial Type
6.4 Subjects Recruited for Neuro Endocrine (Carcinoid) Carcinoma Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials- Phase
7.2 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials- Phase
7.3 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials- Phase
7.4 Ongoing Neuro Endocrine (Carcinoid) Carcinoma Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Country
Figure 2: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Phase of Development, 2018
Figure 3: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Status, 2018
Figure 4: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Type, 2018
Figure 5: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials Split by Region, 2000-2018
Figure 6: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Type of Economy, 2018
Figure 7: Neuro Endocrine (Carcinoid) Carcinoma- Enrolment by Phase, 2018
Figure 8: Neuro Endocrine (Carcinoid) Carcinoma- Enrolment by Trial Type, 2018
Figure 9: Neuro Endocrine (Carcinoid) Carcinoma- Enrolment by Recruitment Status, 2018
Figure 10: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Sponsor Type, 2018
Figure 11: Neuro Endocrine (Carcinoid) Carcinoma- Enrolment by Type of Sponsors
Figure 12: Neuro Endocrine (Carcinoid) Carcinoma- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Sponsor Type, 2018
Table 2: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Economy Type, 2018
Table 3: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials by Region, 2018
Table 4: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Neuro Endocrine (Carcinoid) Carcinoma- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Neuro Endocrine (Carcinoid) Carcinoma- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Neuro Endocrine (Carcinoid) Carcinoma- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Neuro Endocrine (Carcinoid) Carcinoma- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Neuro Endocrine (Carcinoid) Carcinoma- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company